MLICM
INCY icon

Metropolitan Life Insurance Company (MetLife)’s Incyte INCY Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,502
Closed -$427K – 1029
2024
Q1 		$427K Sell
7,502
-68
-0.9% -$4.08K 0.02% 502
2023
Q4 		$475K Sell
7,570
-125
-2% -$7.07K 0.02% 473
2023
Q3 		$445K Sell
7,695
-373
-5% -$23.5K 0.02% 463
2023
Q2 		$502K Sell
8,068
-208
-3% -$13.9K 0.02% 460
2023
Q1 		$598K Sell
8,276
-1,969
-19% -$154K 0.03% 428
2022
Q4 		$823K Sell
10,245
-577
-5% -$44.1K 0.04% 408
2022
Q3 		$721K Sell
10,822
-345
-3% -$25.5K 0.03% 425
2022
Q2 		$848K Sell
11,167
-273
-2% -$20.7K 0.04% 405
2022
Q1 		$909K Sell
11,440
-17,156
-60% -$1.25M 0.03% 437
2021
Q4 		$2.1M Sell
28,596
-621
-2% -$41.9K 0.03% 501
2021
Q3 		$2.01M Sell
29,217
-890
-3% -$67.6K 0.03% 505
2021
Q2 		$2.53M Sell
30,107
-2,283
-7% -$190K 0.04% 421
2021
Q1 		$2.63M Sell
32,390
-1,646
-5% -$140K 0.04% 396
2020
Q4 		$2.96M Sell
34,036
-1,139
-3% -$98.5K 0.04% 342
2020
Q3 		$3.16M Sell
35,175
-782
-2% -$75.4K 0.05% 287
2020
Q2 		$3.74M Buy
35,957
+1,160
+3% +$112K 0.07% 232
2020
Q1 		$2.55M Sell
34,797
-359
-1% -$27.1K 0.05% 307
2019
Q4 		$3.07M Sell
35,156
-423
-1% -$36.1K 0.05% 335
2019
Q3 		$2.64M Buy
35,579
+321
+0.9% +$25.9K 0.04% 373
2019
Q2 		$3M Buy
35,258
+1,624
+5% +$130K 0.05% 329
2019
Q1 		$2.89M Sell
33,634
-956
-3% -$77.8K 0.05% 313
2018
Q4 		$2.2M Buy
34,590
+120
+0.3% +$7.79K 0.04% 375
2018
Q3 		$2.38M Sell
34,470
-736
-2% -$50.5K 0.04% 422
2018
Q2 		$2.36M Buy
35,206
+432
+1% +$29.5K 0.04% 429
2018
Q1 		$2.9M Buy
34,774
+220
+0.6% +$19.8K 0.04% 340
2017
Q4 		$3.27M Sell
34,554
-53,577
-61% -$5.6M 0.04% 308
2017
Q3 		$10.3M Sell
88,131
-782
-0.9% -$98.9K 0.06% 268
2017
Q2 		$11.2M Sell
88,913
-3,976
-4% -$506K 0.08% 239
2017
Q1 		$12.4M Buy
92,889
+81,705
+731% +$10.4M 0.09% 226
2016
Q4 		$1.12M Sell
11,184
-503
-4% -$49.1K 0.01% 1237
2016
Q3 		$1.1M Sell
11,687
-561
-5% -$47.3K 0.01% 1226
2016
Q2 		$980K Buy
12,248
+521
+4% +$40.4K 0.01% 1265
2016
Q1 		$850K Hold
11,727
– – 0.01% 1257
2015
Q4 		$1.27M Buy
11,727
+313
+3% +$34.9K 0.01% 1062
2015
Q3 		$1.26M Hold
11,414
– – 0.01% 1075
2015
Q2 		$1.19M Buy
+11,414
New +$1.18M 0.01% 1175
2015
Q1 		– Sell
-10,193
Closed -$745K – 2317
2014
Q4 		$745K Buy
10,193
+272
+3% +$17.8K 0.01% 1514
2014
Q3 		$487K Sell
9,921
-75
-0.8% -$3.76K ﹤0.01% 1736
2014
Q2 		$564K Buy
9,996
+2,917
+41% +$149K ﹤0.01% 1750
2014
Q1 		$379K Hold
7,079
– – ﹤0.01% 1996
2013
Q4 		$358K Hold
7,079
– – ﹤0.01% 2042
2013
Q3 		$270K Sell
7,079
-95
-1% -$2.8K ﹤0.01% 2188
2013
Q2 		$158K Buy
+7,174
New +$157K ﹤0.01% 2514

Other funds holding INCY

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s INCY Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Incyte (INCY) in Q2 2024, closing a stake of 7,502 shares — an estimated $427K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INCY in Q2 2013 and held it in 43 quarters. The position peaked at $12.4M in Q1 2017. 583 funds tracked by Wall St. Rank hold INCY as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Incyte position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,502 Incyte shares in Q2 2024, an estimated $427K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Incyte in Q2 2013 and held it in 43 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Incyte position peaked at $12.4M in Q1 2017.
  • 583 funds tracked by Wall St. Rank held Incyte as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.